Kevzara

Product manufactured by Sanofi-Aventis U.s. Llc

Application Nr Approved Date Route Status External Links
BLA761037 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Kevzara ® Is Indicated For Treatment Of Adult Patients With Moderately To Severely Active Rheumatoid Arthritis (Ra) Who Have Had An Inadequate Response Or Intolerance To One Or More Disease-Modifying Antirheumatic Drugs (Dmards). Kevzara ® Is An Interleukin-6 (Il-6) Receptor Antagonist Indicated For Treatment Of Adult Patients With Moderately To Severely Active Rheumatoid Arthritis Who Have Had An Inadequate Response Or Intolerance To One Or More Disease-Modifying Antirheumatic Drugs (Dmards). ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Sarilumab

Comments